Ohcanbohtosat - Novick D

Predictors of duloxetine adherence and persistence in patients with fibromyalgia Dahkki Cui Z, Zhao Y, Novick D, Faries D

Viečča ollesdeavstta

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia Dahkki Peng X, Sun P, Novick D, Andrews J, Sun S

Viečča ollesdeavstta

Sex differences in the course of schizophrenia across diverse regions of the world Dahkki Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM

Viečča ollesdeavstta

Impact of anxiety symptoms on outcomes of depression: an observational study in Asian patients Dahkki Novick D, Montgomery W, Aguado J, Peng X, Haro JM

Viečča ollesdeavstta

Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Databa... Dahkki Reed C, Hong J, Novick D, Lenox-Smith A, Happich M

Viečča ollesdeavstta

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study Dahkki Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM

Viečča ollesdeavstta

Recovery in patients with major depressive disorder (MDD): results of a 6-month, multinational, observational study Dahkki Novick D, Montgomery W, Vorstenbosch E, Moneta MV, Dueñas H, Haro JM

Viečča ollesdeavstta

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia Dahkki Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM

Viečča ollesdeavstta

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care Dahkki Andrews JS, Wu N, Chen SY, Yu X, Peng XM, Novick D

Viečča ollesdeavstta

Antidepressant medication treatment patterns in Asian patients with major depressive disorder Dahkki Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM

Viečča ollesdeavstta

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder Dahkki Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM

Viečča ollesdeavstta

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity? Dahkki Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM

Viečča ollesdeavstta

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection Dahkki Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Viečča ollesdeavstta

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting Dahkki Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM

Viečča ollesdeavstta

Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Dahkki Koyasu, S, Lawton, T, Novick, D, Recny, M A, Siliciano, R F, Wallner, B P, Reinherz, E L

Viečča ollesdeavstta
Viečča ollesdeavstta
Viečča ollesdeavstta

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia Dahkki Novick D, Montgomery W, Haro JM, Moneta MV, Zhu G, Yue L, Hong J, Duenas H, Brugnoli R

Viečča ollesdeavstta

Differential signal transduction via T-cell receptor CD3 zeta 2, CD3 zeta-eta, and CD3 eta 2 isoforms. Dahkki Bauer, A, McConkey, D J, Howard, F D, Clayton, L K, Novick, D, Koyasu, S, Reinherz, E L

Viečča ollesdeavstta
Viečča ollesdeavstta
Viečča ollesdeavstta

Two antiviral proteins from tobacco: purification and characterization by monoclonal antibodies to human beta-interferon. Dahkki Edelbaum, O, Ilan, N, Grafi, G, Sher, N, Stram, Y, Novick, D, Tal, N, Sela, I, Rubinstein, M

Viečča ollesdeavstta
Viečča ollesdeavstta
Viečča ollesdeavstta

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline Dahkki Huang J, Wang Y, Chen J, Zhang Y, Yuan Z, Yue L, Haro JM, Moneta MV, Novick D, Fang YR

Viečča ollesdeavstta